Schneider H G, Kartsogiannis V, Zhou H, Chou S T, Martin T J, Grill V
Department of Endocrinology, Austin and Repatriation Medical Center, Melbourne, Australia.
J Bone Miner Res. 1998 Oct;13(10):1640-3. doi: 10.1359/jbmr.1998.13.10.1640.
Multiple myeloma frequently leads to complications, such as osteolytic lesions, hypercalcemia, and pathological fractures. Increased bone resorption in myeloma is due to osteoclast activation. The nature of the osteoclast activator(s) remains unclear. We describe a case of multiple myeloma with marked hypercalcemia and skeletal complications that progressed rapidly despite chemotherapy. The patient had marked hypercalcemia at diagnosis (4.5 mmol/l), and elevated parathyroid hormone-related protein (PTHrP) levels were found in plasma. Analysis of the bone marrow trephine biopsy showed PTHrP gene transcription and protein in myeloma cells. These results provide strong evidence for the production of significant amounts of PTHrP by human myeloma cells. PTHrP has been measured as elevated in the plasma of patients with myeloma and might be an important contributor to the skeletal complications in this disease.
多发性骨髓瘤常导致并发症,如溶骨性病变、高钙血症和病理性骨折。骨髓瘤中骨吸收增加是由于破骨细胞活化所致。破骨细胞激活剂的性质尚不清楚。我们描述了一例多发性骨髓瘤患者,其伴有明显的高钙血症和骨骼并发症,尽管接受了化疗,病情仍迅速进展。该患者诊断时血钙明显升高(4.5 mmol/l),血浆中甲状旁腺激素相关蛋白(PTHrP)水平升高。骨髓活检组织切片分析显示骨髓瘤细胞中有PTHrP基因转录和蛋白表达。这些结果为人类骨髓瘤细胞产生大量PTHrP提供了有力证据。在骨髓瘤患者的血浆中检测到PTHrP水平升高,它可能是该疾病骨骼并发症的一个重要促成因素。